Top 10 Players in the Vietnam Kawasaki Disease Market | Insights 2026

Top 10 Players in the Vietnam Kawasaki Disease Market

The VietnamKawasaki Disease (KD) market is at a critical juncture for specialized paediatric immunology, sourcing of high-grade plasma-derived therapies, and reliability of clinical diagnostics. Kawasaki disease is a systemic vasculitis requiring early treatment, usually with high-dose intravenous immunoglobulin (IVIG) and aspirin, to reduce the risk of coronary artery lesions.

Vietnam Kawasaki Disease Market Overview

According to 6Wresearch, the Vietnam Kawasaki Disease Market is growing substantially, driven by the increase in clinical awareness, and emphasis on early and standardized IVIG administration to prevent long-term cardiac morbidity. KD is a systemic inflammatory disorder, that necessitates a complex hospital-based infrastructure, for acute treatment and longitudinal follow-up.

The market is influenced by the Ministry of Health and private healthcare networks, which give access to essential therapies. Along with this, partnerships between regional paediatric specialists and global pharma innovators ensure Vietnam’s position as a region of critical importance for the treatment of inflammatory disorders in children, with increasing demands for quality diagnostic and therapeutic biologics.

Competitive Landscape

The competitive landscape of the Vietnam Kawasaki Disease industry is characterized by multinational pharmaceutical leaders and major domestic players, offering essential biologics, anti-inflammatories, and critical care infrastructure. The leading companies sustain their market share through rigorous adherence to quality standards, and active cooperation with national paediatric specialty hospitals and research institutes.

Below is a list of leading players operating in the Vietnam Kawasaki Disease Market:

1. DHG Pharma (Dược Hậu Giang)

DHG Pharma (Dược Hậu Giang) is the largest domestic pharmaceutical manufacturer, providing a broad network of essential medications and supportive care solutions for paediatric health.

2. Takeda Vietnam

Takeda Vietnam is a critical supplier of high-quality, plasma-derived immunoglobulin therapies globally and in Vietnam, essential for the acute management of vasculitis.

3. Imexpharm Corporation

Imexpharm Corporation is renowned for its EU-GMP certified manufacturing facilities, providing high-quality generic therapeutics supporting systemic health management.

4. Pfizer Vietnam

Pfizer Vietnam focuses on providing specialized therapies and supporting advanced clinical needs for cardiovascular and immune-related paediatric care.

5. Novartis Vietnam

Novartis Vietnam bridges the gap between innovative research and local clinical application by delivering therapeutic solutions for complex inflammatory diseases.

6. Bidiphar (Binh Dinh Pharmaceutical and Equipment)

Bidiphar (Binh Dinh Pharmaceutical and Equipment) is a major domestic player providing essential medical equipment and pharmaceutical products vital for hospital-based paediatric care.

7. Roche Vietnam

Roche Vietnam contributes through its global expertise in specialized diagnostics and advanced biologics, assisting in the early identification of inflammatory systemic conditions.

8. Sanofi Vietnam

Sanofi Vietnam specializes in immunology and complex drug portfolios, facilitating access to niche therapeutic options for paediatric inflammatory responses.

9. Traphaco

Traphaco is a forward-thinking leader in the Vietnamese market, focusing on research and development to supply the paediatric supply chain with integrated health solutions.

10. Abbott Vietnam

Abbott Vietnam provides vital diagnostic tools and specialized nutritional support, critical in the holistic, long-term management of paediatric recovery.

Top 10 Players in the Vietnam Kawasaki Disease Market: FAQs